Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by pabalooon Jun 22, 2020 11:50am

44 Views

Post# 31176771

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bausch VERY happy with Trulance performance

Fara is the new Bozo. You have now won the crown as the biggest Bizo Fara Swapper is now the Bilbo. Lol yes someone decided to sell 1000 shares for 60 bucks less than he should have. Good for him. Keep investing is GDNP it's going to zero which is about another dime clown.

Bullboard Posts

Nvidia reports record revenue in Q3